CytomX Therapeutics, Inc.
CTMX
Health Care
2
exclusion reasons
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
CytomX Therapeutics is a biotechnology company whose research and development activities involve animal testing. The company's preclinical studies utilize animal models as part of its therapeutic development process. This record is based on a general classification from Cruelty Free Investors; no specific, recent evidence detailing the scale or nature of CytomX's animal testing activities has been gathered for this review.
CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company. Its core business is the discovery and development of novel antibody-based cancer therapies. The preclinical development of such investigational drugs, as detailed in the company's financial filings, requires the completion of nonclinical laboratory tests and animal studies to assess safety and efficacy before human trials can begin. This process inherently involves animal testing as a standard, required component of pharmaceutical development and regulatory compliance.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.